OUTLOOK THERAPEUTICS, INC. (OTLK)

Import this data to Google Sheets with:

=jivedata("OTLK","financials")

Full statements spill as a table. For one cell: =jivedata("OTLK","Revenue") or =jivedata("OTLK","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

OUTLOOK THERAPEUTICS, INC.

OTLK • CIK 0001649989

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	—	$1,413.535	$1,413.535
Cost of Goods and Services Sold	—	—	$1,356.33	$1,112.433
Gross Profit	—	—	$57.205	$-2,275.914
Operating Income (Loss)	$-53,126.382	$-71,703.235	$-67,061.666	$-55,635.754
Income (Loss) from Equity Method Investments	$-10.998	$-100.742	$-141.007	$-165.184
Investment Income, Interest	—	$906.15	$89.738	$89.738
Interest Income (Expense), Net	$-1,559.748	—	$-283.128	$-264.146
Fair Value Adjustment of Warrants	$-50.919	$-38,638.042	$-43,015.831	$307.114
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-58,979.868	$-75,363.914	$-63,976.692	$-62,677.885
Income Tax Expense (Benefit)	$2.8	$2.8	$-1,551.829	$-1,551.829
Net Income (Loss) Available to Common Stockholders, Basic	$-58,982.668	$-75,366.714	$-62,424.863	$-61,123.256
Research and Development Expense	$26,452.942	$41,763.047	$27,180.64	$17,364.736
Selling, General and Administrative Expense	—	—	$39,938.231	$35,995.104
Weighted Average Number of Shares Outstanding, Basic	250,176,633	18,548,813	34,796,120	97,364,192

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$23,391.982	$14,927.538	$8,083.085	$11,242.068
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	$1,490.931	$1,644.291
Operating Lease, Right-of-Use Asset	$26.172	$274.645	$225.508	$185.183
Inventory, Net	—	—	$3,338.404	$5,043.53
Equity Method Investments	$793.932	$693.19	$552.183	$2,527.418
Prepaid Expense and Other Assets, Current	$7,587.216	$12,488.498	$4,476.549	$5,238.312
Other Assets, Noncurrent	$501.299	$439.283	$417.523	$304.048
Assets, Current	$30,979.198	$27,416.036	$17,388.969	$23,168.201
Assets	$32,300.601	$28,823.154	$18,584.183	$26,184.85
Operating Lease, Liability, Noncurrent	—	$246.922	$188.801	$140.128
Warrants and Rights Outstanding	$6.219	$59,099.013	$4,768.438	$7,758.238
Liabilities	$46,738.378	$101,899.664	$50,771.844	$36,577.417
Notes and Loans Payable, Current	$35,551	$29,440	$29,947	$9,845
Operating Lease, Liability, Current	$26.995	$50.907	$58.897	$64.016
Accounts Payable, Current	$6,574.523	$7,968.725	$10,192.388	$6,807.296
Accrued Liabilities, Current	$2,745.74	$3,237.468	$5,314.32	$3,278.739
Accrued Income Taxes, Current	$1,856.629	$1,856.629	$302	$302
Liabilities, Current	$46,732.159	$42,553.729	$45,814.605	$28,679.051
Common Stock, Value, Issued	$2,602.574	$239.057	$538.873	$1,870.971
Additional Paid in Capital, Common Stock	$450,877.835	$469,969.333	$572,983.229	$641,276.712
Retained Earnings (Accumulated Deficit)	$-467,918.186	$-543,284.9	$-605,709.763	$-653,540.25
Stockholders' Equity Attributable to Parent	$-14,437.777	$-73,076.51	$-32,187.661	$-10,392.567
Preferred Stock, Shares Authorized	7,300,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	425,000,000	60,000,000	260,000,000	260,000,000
Common Stock, Shares, Issued	260,257,517	23,905,635	53,887,233	187,096,998

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-58,982.668	$-75,366.714	$-62,424.863	$-61,123.256
Net Cash Provided by (Used in) Operating Activities	$-42,973.398	$-68,793.858	$-51,829.437	$-56,154.885
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$5,995.17	$-8,464.444	$-6,844.453	$2,341.254
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$23,391.982	$14,927.538	$8,083.085	$11,057.933
Depreciation, Depletion and Amortization, Nonproduction	$44.188	$113.859	$117.052	$104.019
Proceeds from Issuance of Common Stock	$30,024.213	$60,333.681	$25,396.398	$55,111.544
Paid-in-Kind Interest	$2,529.83	$2,681.847	$2,681.847	$2,681.847
Proceeds from Warrant Exercises	$188.1	—	$22,631.172	$10,718.325
Share-based Payment Arrangement, Noncash Expense	$5,547.019	$5,385.124	$8,897.887	$4,250.859
Proceeds from Issuance of Debt	$30,000	$30,000	$33,100	$17,000
Finance Lease, Principal Payments	$11.751	$4.267	$4.267	$4.267
Repayments of Debt	$10,220	$10,220	$36,142.586	$20,232.558
Net Cash Provided by (Used in) Financing Activities	$48,968.568	$60,329.414	$44,984.984	$60,596.139
Fair Value Adjustment of Warrants	$-50.919	$-38,638.042	$-43,015.831	$307.114
Income (Loss) from Equity Method Investments	$-10.998	$-100.742	$-141.007	$-165.184
Interest Paid, Excluding Capitalized Interest, Operating Activities	$1,160.008	$475	$475	$475
Debt Conversion, Original Debt, Amount	$25	$11,250	$2,525	$20,614.784
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction	—	$141.6	$49.092	$49.092
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	—	$294.416	$294.416	$294.416
Increase (Decrease) in Accounts Receivable	—	—	$1,490.931	$-107.131
Increase (Decrease) in Inventories	—	—	$3,338.404	$916.814
Increase (Decrease) in Prepaid Expense and Other Assets	$-2,616.925	$4,901.282	$-8,011.949	$-1,079.02
Increase (Decrease) in Other Noncurrent Assets	$208.203	$5.9	$95.247	$95.247
IncreaseDecreaseInOperatingLeaseLiability	$-26.995	$3.413	$-50.131	$-56.561
Increase (Decrease) in Accounts Payable	$3,083.038	$1,394.202	$1,666.049	$-3,598.154
Increase (Decrease) in Accrued Liabilities	$-711.661	$491.728	$1,710.195	$-1,314.222
Increase (Decrease) in Income Taxes	—	—	$-1,554.629	$-1,554.629

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("OTLK","financials")

Full statements spill as a table. For one cell: =jivedata("OTLK","Revenue") or =jivedata("OTLK","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.